Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC575117476;17477;17478 chr2:178731515;178731514;178731513chr2:179596242;179596241;179596240
N2AB543416525;16526;16527 chr2:178731515;178731514;178731513chr2:179596242;179596241;179596240
N2A450713744;13745;13746 chr2:178731515;178731514;178731513chr2:179596242;179596241;179596240
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCC
  • RefSeq wild type template codon: CGG
  • Domain: Ig-41
  • Domain position: 22
  • Structural Position: 33
  • Q(SASA): 0.1146
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T rs759726984 -1.333 0.505 N 0.726 0.113 0.143124449307 gnomAD-2.1.1 8.07E-06 None None None None N None 0 0 None 0 0 None 3.27E-05 None 0 8.92E-06 0
A/T rs759726984 -1.333 0.505 N 0.726 0.113 0.143124449307 gnomAD-4.0.0 6.84399E-06 None None None None N None 0 0 None 0 0 None 0 0 3.59846E-06 4.63833E-05 3.31444E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.5227 ambiguous 0.4559 ambiguous -1.064 Destabilizing 0.01 N 0.435 neutral None None None None N
A/D 0.9779 likely_pathogenic 0.9696 pathogenic -2.403 Highly Destabilizing 0.782 D 0.864 deleterious N 0.506965368 None None N
A/E 0.9731 likely_pathogenic 0.9602 pathogenic -2.195 Highly Destabilizing 0.906 D 0.818 deleterious None None None None N
A/F 0.9195 likely_pathogenic 0.9042 pathogenic -0.621 Destabilizing 0.967 D 0.893 deleterious None None None None N
A/G 0.1786 likely_benign 0.1732 benign -1.521 Destabilizing 0.001 N 0.395 neutral N 0.450765369 None None N
A/H 0.9876 likely_pathogenic 0.9826 pathogenic -2.041 Highly Destabilizing 0.991 D 0.883 deleterious None None None None N
A/I 0.7196 likely_pathogenic 0.715 pathogenic 0.293 Stabilizing 0.826 D 0.818 deleterious None None None None N
A/K 0.995 likely_pathogenic 0.992 pathogenic -1.164 Destabilizing 0.826 D 0.821 deleterious None None None None N
A/L 0.6631 likely_pathogenic 0.6258 pathogenic 0.293 Stabilizing 0.404 N 0.817 deleterious None None None None N
A/M 0.7089 likely_pathogenic 0.6914 pathogenic 0.029 Stabilizing 0.991 D 0.804 deleterious None None None None N
A/N 0.9362 likely_pathogenic 0.9181 pathogenic -1.483 Destabilizing 0.826 D 0.879 deleterious None None None None N
A/P 0.9896 likely_pathogenic 0.9838 pathogenic -0.104 Destabilizing 0.879 D 0.817 deleterious N 0.506965368 None None N
A/Q 0.9726 likely_pathogenic 0.9622 pathogenic -1.268 Destabilizing 0.906 D 0.803 deleterious None None None None N
A/R 0.9883 likely_pathogenic 0.9812 pathogenic -1.289 Destabilizing 0.906 D 0.806 deleterious None None None None N
A/S 0.2192 likely_benign 0.2349 benign -1.875 Destabilizing 0.338 N 0.679 prob.neutral N 0.444666116 None None N
A/T 0.2045 likely_benign 0.1928 benign -1.541 Destabilizing 0.505 D 0.726 prob.delet. N 0.469004413 None None N
A/V 0.3282 likely_benign 0.3153 benign -0.104 Destabilizing 0.505 D 0.718 prob.delet. N 0.447298202 None None N
A/W 0.9919 likely_pathogenic 0.9899 pathogenic -1.47 Destabilizing 0.991 D 0.895 deleterious None None None None N
A/Y 0.9662 likely_pathogenic 0.9548 pathogenic -0.881 Destabilizing 0.967 D 0.896 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.